Status:
COMPLETED
Sunitinib and Atrial Trabeculae Contractility
Lead Sponsor:
Radboud University Medical Center
Conditions:
Cardiotoxicity
Ischemia
Eligibility:
All Genders
18+ years
Brief Summary
Rationale: Recently, sunitinib (a tyrosine kinase inhibitor that is used for treatment of metastatic renal carcinoma and gastrointestinal stroma tumors) has been associated with development of heart ...
Detailed Description
Study population: 44 (+22) patients undergoing CABG cardiac surgery with extracorporal circulation Intervention (if applicable): none (pharmacological interventions will only be performed ex-vivo in i...
Eligibility Criteria
Inclusion
- Cardiac surgery with extracorporal circulation
Exclusion
- Use of oral antiarrhythmics
- theophylline use
- Use of sulfonylureas
- Atrial arrythmias
- Right ventricular failure
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT01246778
Start Date
November 1 2010
End Date
April 1 2014
Last Update
May 1 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboud University Nijmegen Medical Centre
Nijmegen, Netherlands, 6500HB